Echo IQ (ASX:EIQ) Competitors

Our mission is to transform radiology. Radiology Partners, through its owned and affiliated practices, is a leading radiology practice in the U.S., serving hospitals and other healthcare facilities across the nation. As a physician-led and physician-owned practice, we advance our bold mission by innovating across clinical value, technology, service and economics, while elevating the role of radiology and radiologists in healthcare. Using a proven healthcare services model, Radiology Partners provides consistent, high quality care to patients, while delivering enhanced value to the hospitals, clinics, imaging centers and referring physicians we serve. Our values are foundational to all we do and are woven through our cultural fabric. • Integrity: We are truthful with others and ourselves. Our words are consistent with our beliefs. Our actions are consistent with our words. • Teamwork: We work together. The best of us alone cannot exceed the impact of all of us together. We support, respect and value each other. • Excellence: We put forth our personal and professional best. We provide the highest level of care possible and deliver superior experiences to our patients, referring physicians and clients. • Service: We are here to serve. We strive to understand the needs of our clients – especially patients and referring physicians – and exceed their expectations. • Accountability: We take responsibility for our actions. We acknowledge that each of us has a role in the success of our Practice. Learn more at RadPartners.com.

RadNet, Inc. is the largest U.S. provider of freestanding outpatient diagnostic imaging services, operating over 400 centers across key markets, including Arizona, California, Florida, and New York. In addition to imaging, RadNet offers AI-driven solutions under the DeepHealth brand, radiology IT, and teleradiology services. With over 10,000 employees and affiliated radiologists, RadNet is dedicated to advancing healthcare through innovation and expertise.

Lunit is a leading provider of AI solutions for cancer diagnostics and therapeutics, with a mission to conquer cancer through AI. Our clinically proven AI enables healthcare providers to detect cancer earlier, make more precise treatment decisions, and improve patient outcomes — transforming how cancer is diagnosed and treated. Our technology spans the entire cancer continuum, from risk prediction and screening optimization to early detection and precision oncology. Lunit’s breast and chest imaging AI boosts diagnostic accuracy and efficiency, while our pathology AI is leveraged by leading pharmaceutical companies to drive biomarker discovery and companion diagnostics (CDx) development. Trusted by 10,000+ sites across 65+ countries, Lunit continues to redefine global standards in data-driven cancer care. Learn more about our technology and mission at www.lunit.io/en